275 related articles for article (PubMed ID: 32780509)
21. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
22. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
23. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
24. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
25. Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Xiao Y; Tu Y; Li Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33792624
[TBL] [Abstract][Full Text] [Related]
26. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
27. A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer.
Gong J; Li Y; Liu CJ; Xiang Y; Li C; Ye Y; Zhang Z; Hawke DH; Park PK; Diao L; Putkey JA; Yang L; Guo AY; Lin C; Han L
Cell Rep; 2017 Nov; 21(7):1968-1981. PubMed ID: 29141226
[TBL] [Abstract][Full Text] [Related]
28. The genetic and pharmacogenomic landscape of snoRNAs in human cancer.
Liu Y; Ruan H; Li S; Ye Y; Hong W; Gong J; Zhang Z; Jing Y; Zhang X; Diao L; Han L
Mol Cancer; 2020 Jun; 19(1):108. PubMed ID: 32576192
[TBL] [Abstract][Full Text] [Related]
29. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
30. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
31. Small Nucleolar RNAs (snoRNAs)-Based Risk Score Classifier Predicts Overall Survival in Bladder Carcinoma.
He RQ; Huang ZG; Zhai GQ; Huang SN; Gu YY; Gu YY; Chen G; Ma J; Cheng JW; Yan HB; Li SH
Med Sci Monit; 2020 Oct; 26():e926273. PubMed ID: 33104528
[TBL] [Abstract][Full Text] [Related]
32. A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients.
Zhou Y; Yin W; Kuang Y; Wu Z; Huang H; Liu W; Jiang X; Ren C
Front Immunol; 2023; 14():1138363. PubMed ID: 38022536
[TBL] [Abstract][Full Text] [Related]
33. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
34. Can small nucleolar RNA be a novel molecular target for hepatocellular carcinoma?
Shuwen H; Xi Y; Quan Q; Yin J; Miao D
Gene; 2020 Apr; 733():144384. PubMed ID: 31978508
[TBL] [Abstract][Full Text] [Related]
35. TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling.
Fu X; Cheng S; Wang W; Shi O; Gao F; Li Y; Wang Q
Cancer Genet; 2021 Jun; 254-255():40-47. PubMed ID: 33588182
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
37. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
38. Small nucleolar RNA and its potential role in breast cancer - A comprehensive review.
Dsouza VL; Adiga D; Sriharikrishnaa S; Suresh PS; Chatterjee A; Kabekkodu SP
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188501. PubMed ID: 33400969
[TBL] [Abstract][Full Text] [Related]
39. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
40. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
